Ottavia Dipasquale

Ottavia Dipasquale

Auto-generated profile, based on publicly available information

Ottavia Dipasquale

Olea Medical; La Ciotat, France.

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2021 in Cell Reports
Verified
Journal Article
Open access
DMDaniel Martins
Daniel Martins
AGAlessio Giacomel
Alessio Giacomel
SWSteven C.R. Williams
Steven C.R. Williams
FTFederico Turkheimer
Federico Turkheimer
ODOttavia Dipasquale
Ottavia Dipasquale
MVMattia Veronese
Mattia Veronese
The integration of transcriptomic and neuroimaging data, "imaging transcriptomics," has recently emerged to generate hypotheses about potential biological pathways underlying regional variability in neuroimaging features. However, the validity of this approach is yet to be examined in depth. Here, we sought to bridge this gap by performing transcriptomic decoding of the regional distribution of well-known molecular markers spanning different elements of the biology of the healthy human brain. Imaging transcriptomics identifies biological and cell pathways that are consistent with the known biology of a wide range of molecular neuroimaging markers. The extent to which it can capture patterns of gene expression that align well with elements of the biology of the neuroinflammatory axis, at least in healthy controls without a proinflammatory challenge, is inconclusive. Imaging transcriptomics might constitute an interesting approach to improve our understanding of the biological pathways underlying regional variability in a wide range of neuroimaging phenotypes.

21 March 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ODOttavia Dipasquale
Ottavia Dipasquale
ASArjun Sethi
Arjun Sethi
MLMaria Marcella Laganà
Maria Marcella Laganà
FBFrancesca Baglio
Francesca Baglio
GBGiuseppe Baselli
Giuseppe Baselli
MCMara Cercignani
Mara Cercignani
Artifact removal in resting state fMRI (rfMRI) data remains a serious challenge, with even subtle head motion undermining reliability and reproducibility. Here we compared some of the most popular single-echo de-noising methods—regression of Motion parameters, White matter and Cerebrospinal fluid signals (MWC method), FMRIB’s ICA-based X-noiseifier (FIX) and ICA-based Automatic Removal Of Motion Artifacts (ICA-AROMA)—with a multi-echo approach (ME-ICA) that exploits the linear dependency of BOLD on the echo time. Data were acquired using a clinical scanner and included 30 young, healthy participants (minimal head motion) and 30 Attention Deficit Hyperactivity Disorder patients (greater head motion). De-noising effectiveness was assessed in terms of data quality after each cleanup procedure, ability to uncouple BOLD signal and motion and preservation of default mode network (DMN) functional connectivity. Most cleaning methods showed a positive impact on data quality. However, based on the investigated metrics, ME-ICA was the most robust. It minimized the impact of motion on FC even for high motion participants and preserved DMN functional connectivity structure. The high-quality results obtained using ME-ICA suggest that using a multi-echo EPI sequence, reliable rfMRI data can be obtained in a clinical setting.

1 December 2018 in Neurobiology of Aging
Verified
Journal Article
Open access
LSLaura Serra
Laura Serra
MDMarcello D'Amelio
Marcello D'Amelio
CDCarlotta Di Domenico
Carlotta Di Domenico
ODOttavia Dipasquale
Ottavia Dipasquale
CMCamillo Marra
Camillo Marra
MBMarco Bozzali
Marco Bozzali
We assessed here functional connectivity changes in the locus coeruleus (LC) and ventral tegmental area (VTA) of patients with Alzheimer's disease (AD). We recruited 169 patients with either AD or amnestic mild cognitive impairment due to AD and 37 elderly controls who underwent cognitive and neuropsychiatric assessments and resting-state functional magnetic resonance imaging at 3T. Connectivity was assessed between LC and VTA and the rest of the brain. In amnestic mild cognitive impairment patients, VTA disconnection was predominant with parietal regions, while in AD patients, it involved the posterior nodes of the default-mode network. We also looked at the association between neuropsychiatric symptoms (assessed by the neuropsychiatric inventory) and VTA connectivity. Symptoms such as agitation, irritability, and disinhibition were associated with VTA connectivity with the parahippocampal gyrus and cerebellar vermis, while sleep and eating disorders were associated with VTA connectivity to the striatum and the insular cortex. This suggests a contribution of VTA degeneration to AD pathophysiology and to the occurrence of neuropsychiatric symptoms. We did not find evidence of LC disconnection, but this could be explained by the size of this nucleus, which makes it difficult to isolate. These results are consistent with animal findings and have potential implications for AD prognosis and therapies.

1 July 2019 in NeuroImage
Verified
Journal Article
Open access
ODOttavia Dipasquale
Ottavia Dipasquale
PSPierluigi Selvaggi
Pierluigi Selvaggi
MVMattia Veronese
Mattia Veronese
AGAnthony S. Gabay
Anthony S. Gabay
FTFederico Turkheimer
Federico Turkheimer
MMMitul A. Mehta
Mitul A. Mehta
One of the main limitations of pharmacological fMRI is its inability to provide a molecular insight into the main effect of compounds, leaving an open question about the relationship between drug effects and haemodynamic response. The aim of this study is to investigate the acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on functional connectivity (FC) using a novel multimodal method (Receptor-Enriched Analysis of functional Connectivity by Targets - REACT). This approach enriches the resting state (rs-)fMRI analysis with the molecular information about the distribution density of serotonin receptors in the brain, given the serotonergic action of MDMA. Twenty healthy subjects participated in this double-blind, placebo-controlled, crossover study. A high-resolution in vivo atlas of four serotonin receptors (5-HT1A, 5-HT1B, 5-HT2A, and 5-HT4) and its transporter (5-HTT) was used as a template in a two-step multivariate regression analysis to estimate the spatial maps reflecting the whole-brain connectivity behaviour related to each target under placebo and MDMA. Results showed that the networks exhibiting significant changes after MDMA administration are the ones informed by the 5-HTT and 5-HT1A distribution density maps, which are the main targets of this compound. Changes in the 5-HT1A-enriched functional maps were also associated with the pharmacokinetic levels of MDMA and MDMA-induced FC changes in the 5-HT2A-enriched maps correlated with the spiritual experience subscale of the Altered States of Consciousness Questionnaire. By enriching the rs-fMRI analysis with molecular data of voxel-wise distribution of the serotonin receptors across the brain, we showed that MDMA effects on FC can be understood through the distribution of its main targets. This result supports the ability of this method to characterise the specificity of the functional response of the brain to MDMA binding to serotonergic receptors, paving the way to the definition of a new fingerprint in the characterization of new compounds and potentially to a further understanding to the response to treatment.

7 April 2018 in Journal of Neurology
Verified
Journal Article
Closed access
ETEleonora Tavazzi
Eleonora Tavazzi
NBNiels Bergsland
Niels Bergsland
DCDavide Cattaneo
Davide Cattaneo
EGElisa Gervasoni
Elisa Gervasoni
MLMaria Marcella Laganà
Maria Marcella Laganà
MRMarco Rovaris
Marco Rovaris

21 February 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MVMattia Veronese
Mattia Veronese
LMLucia Moro
Lucia Moro
MAMarco Arcolin
Marco Arcolin
ODOttavia Dipasquale
Ottavia Dipasquale
GRGaia Rizzo
Gaia Rizzo
FTFederico E. Turkheimer
Federico E. Turkheimer
The analysis of structural and functional neuroimaging data using graph theory has increasingly become a popular approach for visualising and understanding anatomical and functional relationships between different cerebral areas. In this work we applied a network-based approach for brain PET studies using population-based covariance matrices, with the aim to explore topological tracer kinetic differences in cross-sectional investigations. Simulations, test-retest studies and applications to cross-sectional datasets from three different tracers ([18F]FDG, [18F]FDOPA and [11C]SB217045) and more than 400 PET scans were investigated to assess the applicability of the methodology in healthy controls and patients. A validation of statistics, including the assessment of false positive differences in parametric versus permutation testing, was also performed. Results showed good reproducibility and general applicability of the method within the range of experimental settings typical of PET neuroimaging studies, with permutation being the method of choice for the statistical analysis. The use of graph theory for the quantification of [18F]FDG brain PET covariance, including the definition of an entropy metric, proved to be particularly relevant for Alzheimer’s disease, showing an association with the progression of the pathology. This study shows that covariance statistics can be applied to PET neuroimaging data to investigate the topological characteristics of the tracer kinetics and its related targets, although sensitivity to experimental variables, group inhomogeneities and image resolution need to be considered when the method is applied to cross-sectional studies.